bronhopest spf
genera d.d., svetonedeljska cesta 2, kalinovica, 10436 rakov potok, hrvatska - atenuirani živi virus zaraznog bronhitisa kokoši, soj h-120 i lentogeni, živi virus newcastleske bolesti, soj la sota - liofilizat za suspenziju - imunološki vmp - kokoši (pilići)
gumpeskal + ib + eds
genera d.d., svetonedeljska 2, kalinovica, rakov potok, hrvatska - virus zarazne bolesti burze, virus newcastleske bolesti, virus zaraznog bronhitisa kokoši i virus sindroma pada nesivosti - emulzija za injekciju - imunološki vmp - kokoši
nobilis ib+nd+eds
intervet international b.v., podružnica u republici hrvatskoj, ivana lučića 2a, 10000 zagreb, hrvatska - inaktivirani virus: zaraznog bronhitisa (ibv), soj m41 (massachusetts), newcastleske bolesti (ndv), soj clone 30 i sindroma pada nesivosti (eds), soj 76 bc14 - emulzija za injekciju - imunološki vmp - kokoši (buduće rasplodne i konzumne nesilice)
nobilis rt+ibmulti+g+nd
intervet international b.v., podružnica u republici hrvatskoj, ivana lučića 2a, 10000 zagreb, hrvatska - inaktivirani virus: zaraznog bronhitisa (ibv), soj m41 (massachusetts) i soj 249g (d274/d207), zaraznog avijarnog rinotraheitisa (artv), soj but1#8544, zarazne bolesti burze (ibdv), soj d78 i newcastleske bolesti (ndv), soj clone 30 - emulzija za injekciju - imunološki vmp - kokoši (buduće rasplodne nesilice)
poulvac ib primer liofilizat za suspenziju za primjenu raspršivanjem, kapanjem u oko ili u vodi za piće, za kokoši
zoetis b.v. podružnica zagreb za promidžbu, petra hektorovića 2, zagreb, hrvatska - živi atenuirani virus zaraznog bronhitisa ptica, soj h120; živi atenuirani virus zaraznog bronhitisa ptica, soj d274 klon - liofilizat za suspenziju - imunološki pripravci za ptice, živo virusno cjepivo za kokoši, virus zaraznog bronhitisa ptica - kokoši
bronhikal ii spf
genera d.d., kalinovica, rakov potok, hrvatska - atenuirani virus zaraznog bronhitisa kokoši, soj h-52 - liofilizat za resuspendiranje - kokoši
nobilis ib 4-91
intervet international b.v., podružnica u republici hrvatskoj, heinzelova 62a, 10000 zagreb, hrvatska - živi, atenuirani virus zaraznog bronhitisa (soj 4-91) ≥3,6 log10 eid50 - liofilizat za resuspendiranje - kokoši
nobilis ib ma5
intervet international b.v., podružnica u republici hrvatskoj, ivana lučića 2a, 10000 zagreb, hrvatska - atenuirani virus zaraznog bronhitisa ptica (soj ma5) - liofilizat za suspenziju - kokoši
ecg plain white paper - 80 mm (pack of 6 rolls)
kardian d.o.o. ulica hondlova 2/9 10000 zagreb -
rinvoq
abbvie deutschland gmbh & co. kg - upadacitinib - artritis, reumatoidni - imunosupresivi - rheumatoid arthritisrinvoq is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (dmards). rinvoq may be used as monotherapy or in combination with methotrexate. psoriatic arthritisrinvoq is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more dmards. rinvoq may be used as monotherapy or in combination with methotrexate. axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)rinvoq is indicated for the treatment of active non-radiographic axial spondyloarthritis in adult patients with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri), who have responded inadequately to nonsteroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)rinvoq is indicated for the treatment of active ankylosing spondylitis in adult patients who have responded inadequately to conventional therapy. atopic dermatitisrinvoq is indicated for the treatment of moderate to severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. ulcerative colitisrinvoq is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent. crohn’s diseaserinvoq is indicated for the treatment of adult patients with moderately to severely active crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.